Target intelligence / Profile preview

GNPNAT1 pseudogene 3 (GNPNAT1P3)

Target
GNPNAT1P3
01

Overview

GNPNAT1 pseudogene 3 (GNPNAT1P3) is classified as a pseudogene of the gene glucosamine-6-phosphate N-acetyltransferase 1 (GNPNAT1). Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional; they usually do not encode functional proteins due to mutations or lack of regulatory elements. There is no evidence in the scientific literature or major genomic/protein databases that GNPNAT1P3 produces a protein product, has any therapeutic relevance, molecular function, biological role, or involvement in human disease. In contrast, its parent gene GNPNAT1 has established functional significance, including roles in cancer biology and cellular metabolism[1][2][3][4][5]. GNPNAT1P3, however, does not appear in current research as a drug target, biomarker, or component of disease pathways. Notes on ambiguity: - "GNPNAT1P3" is sometimes included in genomic annotations, but, as a pseudogene, it does not have a protein product or function. - If you intended to refer to the protein-coding GNPNAT1 gene (rather than this specific pseudogene), please clarify; GNPNAT1 itself is biologically and clinically significant, with roles and disease associations as detailed in sources[1][3][4][5].

Beyond the preview

Go deeper on GNPNAT1 pseudogene 3 (GNPNAT1P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GNPNAT1 pseudogene 3 (GNPNAT1P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call